News

State PBM regulation hits a SCOTUS roadblock
The Supreme Court declined Monday to consider an appellate court’s 2023 decision overturning portions of an Oklahoma law ...
SCOTUS orders judges to revisit decisions on transgender health plans, birth certificates in wake of blockbuster ruling
The Supreme Court on Monday tossed aside a handful of lower court rulings that sided with transgender Americans, requiring ...
The five liberal courts that tied Trump’s hands before SCOTUS clipped their power
Trump administration celebrates Supreme Court's decision restricting nationwide injunctions, as Bondi noted 35 of 40 ...
‘I don’t think Trump read the ruling’: Fmr. DOJ official on Trump claiming 'GIANT WIN' from SCOTUS
George Conway and Former DOJ official Joyce Vance join The Weekend to discuss the Supreme Court's ruling in Trump v. CASA on ...
I Wrote One Of The Books At The Center Of SCOTUS' Scary Ruling. Here's What They Don't Want You To See.
"It’s hard not to feel a chill down your back when you imagine all of the possibilities that could come out of this case." ...
LGBTQ Nation on MSN11hOpinion
SCOTUS lets religious parents opt their kids out of LGBTQ+ books but they can’t opt out of society
SCOTUS just took it from those who need it most Last week, the Supreme Court of the United States handed down a 6-3 decision ...
SCOTUS: Parents can opt kids out of classes with LGBTQ book characters
At issue was whether school systems are required to provide parents with an "opt-out" option when parents claim their ...
SCOTUS guts nationwide blocks on Trump’s orders
In a new ruling, Trump v. CASA, the Supreme Court’s supermajority limited the ability of federal judges to issue universal ...
Pennsylvania is one of 28 states in a legal limbo after SCOTUS birthright ruling. What happens now?
Pennsylvania children of some immigrant couples could be 'stateless' without further court action if President Donald Trump's ...
Fierce Pharma11h
SCOTUS ruling paves smooth launch path for Gilead's long-acting PrEP med Yeztugo, analyst says
As Gilead Sciences gets underway with the key launch of its twice-yearly pre-exposure prophylaxis (PrEP) HIV med, the company ...